Jiangxi Fushine Pharmaceutical (300497.SZ) obtained GMP certification from the Brazilian National Health Surveillance Agency.
Fusheng Pharmaceutical (300497.SZ) announced that the company has obtained approval from the Brazilian National Health Surveillance Agency (ANVISA)...
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has obtained the Good Manufacturing Practice (GMP) certification certificate for drug production quality management issued by the National Health Surveillance Agency (ANVISA) of Brazil. The certification scope is for the active pharmaceutical ingredient: terbinafine.
Related Articles
China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.
Chongqing Sokon Industry Group Stock (09927) signed a "Cooperation Agreement" with the People's Government of Shapingba District, Chongqing City.
On February 6, MNSO (09896) spent $242,400 to repurchase 51,300 shares.
China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.
Chongqing Sokon Industry Group Stock (09927) signed a "Cooperation Agreement" with the People's Government of Shapingba District, Chongqing City.
On February 6, MNSO (09896) spent $242,400 to repurchase 51,300 shares.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
